BALAXI vs ZOTA: Stock Comparison
Zota Health Care Ltd is the larger company by market capitalisation. BALAXI PHARMACEUTICALS LIMITED shows a higher ROE, lower leverage and a higher ROCE, while Zota Health Care Ltd shows a lower P/E, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
BALAXI leads 8; ZOTA leads 5 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | BALAXI | ZOTA |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | BALAXI | ZOTA |
|---|---|---|
| Live Price | ₹22.83 | ₹1,076.8 |
| Day Change | 0.09% | -1.62% |
| Volume | 10,635 | 1.1 L |
| 52-Week High | ₹47.88 | ₹1,740 |
| 52-Week Low | ₹15.2 | ₹1,026.2 |
| Distance from 52W High | -52.32% | -38.11% |
Valuation
| Metric | BALAXI | ZOTA |
|---|---|---|
| Market Cap | ₹127 Cr | ₹3,737 Cr |
| P/E Ratio | 12.63x | -35.61x |
| P/B Ratio | 0x | 5.44x |
| EPS | ₹0.26 | ₹-30.6 |
| Book Value | ₹45.12 | ₹200 |
| Dividend Yield | 0% | 0.09% |
Growth
| Metric | BALAXI | ZOTA |
|---|---|---|
| Revenue Growth (TTM YoY) | -25.76% | 67.7% |
| EPS Growth (TTM YoY) | -58.44% | 0% |
| Qtr Sales Growth | 7.8% | 67.6% |
| Qtr Profit Growth | -95.5% | -204% |
Profitability & Leverage
| Metric | BALAXI | ZOTA |
|---|---|---|
| ROE | 0.57% | -15% |
| ROCE | 13% | -8.47% |
| Net Margin | 0.52% | -13.98% |
| Operating Margin | 3.4% | 0.49% |
| Debt to Equity | 0.22x | 0.39x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | BALAXI | ZOTA |
|---|---|---|
| Promoter Holding | 65.99% | 49.38% |
| FII Holding | 0% | 7.92%▼ 0.29 pp |
| DII Holding | 2.56% | 6.75%▲ 0.35 pp |
| Public Holding | 31.45% | 35.96%▼ 0.04 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BALAXI PHARMACEUTICALS LIMITED and Zota Health Care Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.